Our clinical area is located on the main floor of the MCH. We have nine examination rooms, a treatment room and three testing rooms. We have cutting-edge technology to diagnose and treat conditions such as tumours, retinal detachment and ROP (retinopathy of prematurity), to do imaging and photography and to measure electrical activities of the retina and optic nerve in healthy and blind patients.
At the new MCH at the Glen, we will have more rooms with better flow for testing and clinics. Our research activity will be done near by. We are currently testing the safety and efficacy of the first drug for blindness. We will continue to do clinical research trials at the Glen in a special designated area (Centre for Innovative Medicine). We will continue to provide leading-edge care and perform cutting-edge basic research to understand and treat blindness.